Terms: = Brain cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3 AND Prognosis
5155 results:
1. Biomarkers for prognosis of meningioma patients: A systematic review and meta-analysis.
Aung TM; Ngamjarus C; Proungvitaya T; Saengboonmee C; Proungvitaya S
PLoS One; 2024; 19(5):e0303337. PubMed ID: 38758750
[TBL] [Abstract] [Full Text] [Related]
2. A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.
Woo CS; Ho RS; Ho G; Lau HT; Fong CH; Chang JY; Leung EK; Tang LC; Ma IK; Lee AC; Lui DT; Woo YC; Chow WS; Leung GK; Tan KC; Lam KS; Lee CH
Front Endocrinol (Lausanne); 2024; 15():1368944. PubMed ID: 38756997
[TBL] [Abstract] [Full Text] [Related]
3. Preoperative walking exercise to improve prognosis in patients with supratentorial brain tumours after craniotomy: protocol for a randomised controlled trial.
Qu C; Cao Z; Zhou J; He S; Liu F; Liu Z
BMJ Open; 2024 May; 14(5):e080787. PubMed ID: 38754891
[TBL] [Abstract] [Full Text] [Related]
4. CDCA3 is a potential biomarker for glioma malignancy and targeted therapy.
Han C; Liu S; Ji Y; Hu Y; Zhang J
Medicine (Baltimore); 2024 May; 103(19):e38066. PubMed ID: 38728485
[TBL] [Abstract] [Full Text] [Related]
5. Glioma.
Weller M; Wen PY; Chang SM; Dirven L; Lim M; Monje M; Reifenberger G
Nat Rev Dis Primers; 2024 May; 10(1):33. PubMed ID: 38724526
[TBL] [Abstract] [Full Text] [Related]
6. Pituitary abscess: a descriptive analysis of a series of 19 patients-a multi-center experience.
Xue Q; Shi X; Fu X; Yin Y; Zhou H; Liu S; Sun Q; Meng J; Bian L; Tan H; He H
Eur J Med Res; 2024 May; 29(1):262. PubMed ID: 38698484
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic Implications of Small Cell Lung cancer Transcriptional Subtyping for CNS Metastases.
Tringale KR; Skakodub A; Egger J; Eichholz J; Yu Y; Gomez D; Rimner A; Li B; Yamada Y; Wilcox J; Moss N; Imber BS; Rekhtman N; Baine MK; Rudin CM; Pike LRG
JCO Precis Oncol; 2024 Apr; 8():e2300470. PubMed ID: 38691815
[TBL] [Abstract] [Full Text] [Related]
8. A novel immune cell signature for predicting glioblastoma after radiotherapy prognosis and guiding therapy.
Huang R; Lu X; Sun X; Wu H
Int J Immunopathol Pharmacol; 2024; 38():3946320241249395. PubMed ID: 38687369
[No Abstract] [Full Text] [Related]
9. Roles of TRPM channels in glioma.
Chen Z; Xie H; Liu J; Zhao J; Huang R; Xiang Y; Wu H; Tian D; Bian E; Xiong Z
Cancer Biol Ther; 2024 Dec; 25(1):2338955. PubMed ID: 38680092
[TBL] [Abstract] [Full Text] [Related]
10. [SRSF2 promotes glioblastoma cell proliferation by inducing alternative splicing of FSP1 and inhibiting ferroptosis].
Hua D; Zhou XX; Wang Q; Sun CY; Shi CJ; Luo WJ; Jiang ZD; Yu SZ
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):430-438. PubMed ID: 38678322
[No Abstract] [Full Text] [Related]
11. Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma.
Tomoszková S; Škarda J; Lipina R
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674026
[TBL] [Abstract] [Full Text] [Related]
12. Diffusion- and Perfusion-Weighted MRI Radiomics for Survival Prediction in Patients with Lower-Grade Gliomas.
Park CJ; Kim S; Han K; Ahn SS; Kim D; Park YW; Chang JH; Kim SH; Lee SK
Yonsei Med J; 2024 May; 65(5):283-292. PubMed ID: 38653567
[TBL] [Abstract] [Full Text] [Related]
13. Survival prediction in patients with gynecological cancer irradiated for brain metastases.
Os SS; Skipar K; Skovlund E; Hompland I; Hellebust TP; Guren MG; Lindemann K; Nakken ES
Acta Oncol; 2024 Apr; 63():206-212. PubMed ID: 38647023
[TBL] [Abstract] [Full Text] [Related]
14. Radiotherapy plus temozolomide with or without anlotinib in H3K27M-mutant diffuse midline glioma: A retrospective cohort study.
Liu C; Kuang S; Huang T; Wu J; Zhang L; Gong X
CNS Neurosci Ther; 2024 Apr; 30(4):e14730. PubMed ID: 38644565
[TBL] [Abstract] [Full Text] [Related]
15. Radio-anatomical evaluation of clinical and radiomic profile of multi-parametric magnetic resonance imaging of de novo glioblastoma multiforme.
Ahmed HS; Devaraj T; Singhvi M; Dasan TA; Ranganath P
J Egypt Natl Canc Inst; 2024 Apr; 36(1):13. PubMed ID: 38644430
[TBL] [Abstract] [Full Text] [Related]
16. Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis.
Shi H; Sun X; Wu Y; Cui Q; Sun S; Ji N; Liu Y
J Clin Neurosci; 2024 Jun; 124():36-46. PubMed ID: 38642434
[TBL] [Abstract] [Full Text] [Related]
17. Relationship between chemokine/chemokine receptor and glioma prognosis and outcomes: Systematic review and meta-analysis.
Yang S; Luo M; Yang S; Yuan M; Zeng H; Xia J; Wang N
Int Immunopharmacol; 2024 May; 133():112047. PubMed ID: 38631221
[TBL] [Abstract] [Full Text] [Related]
18. Double pituitary adenomas: report of two cases and systematic review of the literature.
Zhang Y; Gong X; Pu J; Liu J; Ye Z; Zhu H; Lu L; Pan H; Deng K; Yao Y
Front Endocrinol (Lausanne); 2024; 15():1373869. PubMed ID: 38628582
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of autophagy-related protein 7 enhances anti-tumor immune response and improves efficacy of immune checkpoint blockade in microsatellite instability colorectal cancer.
Zhang W; Chen L; Liu J; Chen B; Shi H; Chen H; Qi H; Wu Z; Mao X; Wang X; Huang Y; Li J; Yu Z; Zhong M; Wang T; Li Q
J Exp Clin Cancer Res; 2024 Apr; 43(1):114. PubMed ID: 38627815
[TBL] [Abstract] [Full Text] [Related]
20. Development and validation of a multi-modality fusion deep learning model for differentiating glioblastoma from solitary brain metastases.
Shen S; Li C; Fan Y; Lu S; Yan Z; Liu H; Zhou H; Zhang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Jan; 49(1):58-67. PubMed ID: 38615167
[TBL] [Abstract] [Full Text] [Related]
[Next]
